NDC product
SUPREP Bowel Prep
NDC 24338-177 · Azurity Pharmaceuticals, Inc.
Key facts
| Product NDC | 24338-177 |
|---|---|
| Proprietary name | SUPREP Bowel Prep |
| Nonproprietary name | sodium sulfate, potassium sulfate, magnesium sulfate |
| Substances | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE, UNSPECIFIED FORM |
| Dosage form | SOLUTION, CONCENTRATE |
| Route | ORAL |
| Labeler | Azurity Pharmaceuticals, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA022372 |
| Pharmacologic classes | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA] and 4 more |
| Marketing start | Apr 1, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: